Coloplast A/S (CLPBF)
PNK: CLPBF
· Real-Time Price · USD
98.09
-8.16 (-7.68%)
At close: May 07, 2025, 10:10 AM
Coloplast A/S Income Statement
Financials in DKK. Fiscal
year is
October - September.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 27.45B | 27.03B | 26.3B | 25.53B | 25B | 24.5B | 24.33B | 24.07B | 23.52B | 22.58B | 21.62B | 20.61B | 19.86B | 19.43B | 18.92B | 18.5B | 18.57B |
Cost of Revenue | 8.94B | 8.76B | 8.54B | 8.39B | 8.31B | 8.17B | 7.97B | 7.68B | 7.37B | 7.05B | 6.74B | 6.44B | 6.22B | 6.11B | 5.96B | 5.91B | 5.96B |
Gross Profit | 18.52B | 18.27B | 17.76B | 17.14B | 16.69B | 16.33B | 16.37B | 16.39B | 16.14B | 15.53B | 14.88B | 14.17B | 13.64B | 13.31B | 12.95B | 12.59B | 12.61B |
Operating Income | 7.43B | 7.34B | 7.08B | 6.96B | 6.83B | 6.77B | 6.9B | 6.93B | 6.58B | 6.44B | 6.51B | 6.36B | 6.43B | 6.36B | 5.98B | 5.75B | 5.92B |
Interest Income | 150M | 120M | 121M | 124M | 130M | 109M | 85M | 127M | 135M | 136M | 134M | 99M | 147M | 147M | 147M | 104M | 11M |
Pretax Income | 6.61B | 6.39B | 6.32B | 6.3B | 6.15B | 6.03B | 6.11B | 6.17B | 6B | 6.13B | 6.16B | 6.11B | 6.29B | 6.23B | 5.96B | 5.63B | 5.54B |
Net Income | 4.88B | 5.05B | 4.97B | 4.96B | 4.87B | 4.78B | 4.78B | 4.8B | 4.63B | 4.71B | 4.78B | 4.75B | 4.9B | 4.83B | 4.56B | 4.3B | 4.24B |
Selling & General & Admin | 10.23B | 10.07B | 9.68B | 9.25B | 8.94B | 8.63B | 8.6B | 8.55B | 8.28B | 7.8B | 7.32B | 6.82B | 6.44B | 6.25B | 6.1B | 5.94B | 5.99B |
Research & Development | 899M | 913M | 925M | 901M | 889M | 872M | 858M | 864M | 877M | 866M | 856M | 819M | 774M | 755M | 723M | 720M | 725M |
Other Expenses | -45M | -45M | -2M | -31M | -43M | -44M | -33M | -45M | -44M | -38M | -29M | -11M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.08B | 10.93B | 10.61B | 10.13B | 9.79B | 9.48B | 9.42B | 9.37B | 9.11B | 8.62B | 8.13B | 7.59B | 7.17B | 6.96B | 6.78B | 6.63B | 6.69B |
Interest Expense | 835M | 805M | 799M | 703M | 734M | 682M | 587M | 595M | 431M | 315M | 229M | 97M | 29M | 30M | 35M | 91M | 253M |
Selling & Marketing Expenses | 9.02B | 8.82B | 8.44B | 8.05B | 7.78B | 7.52B | 7.49B | 7.43B | 7.17B | 6.8B | 6.38B | 5.96B | 5.67B | 5.49B | 5.36B | 5.18B | 5.21B |
Cost & Expenses | 20.02B | 19.69B | 19.15B | 18.52B | 18.11B | 17.66B | 17.39B | 17.05B | 16.48B | 15.67B | 14.87B | 14.03B | 13.39B | 13.07B | 12.74B | 12.55B | 12.65B |
Income Tax Expense | 1.73B | 1.34B | 1.35B | 1.33B | 1.28B | 1.24B | 1.33B | 1.37B | 1.37B | 1.42B | 1.38B | 1.36B | 1.4B | 1.41B | 1.4B | 1.33B | 1.3B |
Shares Outstanding (Basic) | 225.3M | 225M | 225.09M | 224.7M | 218.5M | 218.4M | 212.46M | 212.41M | 212.41M | 212.31M | 212.4M | 212.6M | 212.8M | 213.24M | 212.9M | 212.8M | 212.7M |
Shares Outstanding (Diluted) | 225.3M | 225M | 225.09M | 224.7M | 218.5M | 224.66M | 212.71M | 212.41M | 212.41M | 212.8M | 212.71M | 213.04M | 213.25M | 213.28M | 213.27M | 213.21M | 212.7M |
EPS (Basic) | 21.70 | 22.62 | 22.41 | 22.74 | 22.61 | 22.37 | 22.53 | 22.61 | 21.78 | 22.14 | 22.47 | 22.29 | 22.99 | 22.66 | 21.42 | 20.22 | 19.93 |
EPS (Diluted) | 21.70 | 22.62 | 22.25 | 22.57 | 22.44 | 22.20 | 22.51 | 22.59 | 21.75 | 22.10 | 22.44 | 22.26 | 22.96 | 22.64 | 21.39 | 20.18 | 19.90 |
EBITDA | 8.74B | 8.57B | 8.43B | 8.18B | 8.01B | 7.91B | 7.94B | 8.02B | 8B | 7.79B | 7.61B | 7.38B | 7.23B | 7.15B | 6.93B | 6.71B | 6.7B |
EBIT | 7.45B | 7.2B | 7.12B | 7B | 6.89B | 6.71B | 6.7B | 6.77B | 6.43B | 6.44B | 6.39B | 6.2B | 6.43B | 6.37B | 6.19B | 5.92B | 5.89B |
Depreciation & Amortization | 1.31B | 1.29B | 1.23B | 1.17B | 1.12B | 1.07B | 1.05B | 1.05B | 1.02B | 930M | 862M | 811M | 765M | 792M | 751.75M | 756.75M | 780.75M |